Novolog (Pharm-Up 1966) Ltd (TLV:NVLG)

Novolog (Pharm-Up 1966) Income Statement

Financials in millions ILS. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue	1,805	2,022	1,643	1,508	1,255
Revenue Growth (YoY)	-10.70%	23.01%	8.99%	20.13%	10.73%
Cost of Revenue	1,650	1,837	1,470	1,328	1,101
Gross Profit	155.83	184.95	173.76	179.7	154.67
Selling, General & Admin	114.53	115.04	123.29	101.59	83.71
Other Operating Expenses	-4.48	-2.79	-3.49	0.31	1.55
Operating Expenses	110.05	112.25	119.8	101.89	85.26
Operating Income	45.78	72.7	53.97	77.81	69.41
Interest Expense	-19.27	-12.61	-12.87	-12.54	-8.47
Interest & Investment Income	5.4	12.9	12.02	5.54	2.5
Earnings From Equity Investments	1.26	-0.44	-30.64	-4.61	-1.64
Currency Exchange Gain (Loss)	-4.62	-0.72	-0.07	1.36	-0.97
Other Non Operating Income (Expenses)	-	-3.79	-	-	-1.22
EBT Excluding Unusual Items	28.55	68.04	22.4	67.55	59.6
Impairment of Goodwill	-7.15	-7.58	-	-	-
Gain (Loss) on Sale of Investments	-	-	-0.5	-	-
Gain (Loss) on Sale of Assets	0.33	0.17	-0.14	0.34	0.53
Asset Writedown	-	-2.95	-50.67	-	-
Other Unusual Items	-14.9	-	-	-	-
Pretax Income	6.83	57.68	-28.91	67.89	60.13
Income Tax Expense	2.33	16.69	10.47	16.98	15.31
Earnings From Continuing Operations	4.5	41	-39.39	50.91	44.83
Minority Interest in Earnings	-0.38	-1.46	-2.62	-3.4	-2.51
Net Income	4.12	39.54	-42	47.51	42.32
Net Income to Common	4.12	39.54	-42	47.51	42.32
Net Income Growth	-89.59%	-	-	12.27%	5.62%
Shares Outstanding (Basic)	511	511	510	507	505
Shares Outstanding (Diluted)	511	511	511	516	515
Shares Change (YoY)	0.02%	-0.04%	-0.94%	0.14%	9.08%
EPS (Basic)	0.01	0.08	-0.08	0.09	0.08
EPS (Diluted)	0.01	0.08	-0.08	0.09	0.08
EPS Growth	-89.54%	-	-	12.20%	-3.53%
Free Cash Flow	-18.45	145.12	163.77	87.68	52.75
Free Cash Flow Per Share	-0.04	0.28	0.32	0.17	0.10
Dividend Per Share	0.039	0.049	0.029	0.066	0.094
Dividend Growth	-20.02%	66.66%	-55.24%	-30.00%	262.10%
Gross Margin	8.63%	9.15%	10.57%	11.92%	12.32%
Operating Margin	2.54%	3.60%	3.28%	5.16%	5.53%
Profit Margin	0.23%	1.96%	-2.56%	3.15%	3.37%
Free Cash Flow Margin	-1.02%	7.18%	9.96%	5.81%	4.20%
EBITDA	77.3	104.47	135.35	102.12	91.66
EBITDA Margin	4.28%	5.17%	8.24%	6.77%	7.30%
D&A For EBITDA	31.52	31.77	81.38	24.32	22.25
EBIT	45.78	72.7	53.97	77.81	69.41
EBIT Margin	2.54%	3.60%	3.28%	5.16%	5.53%
Effective Tax Rate	34.18%	28.93%	-	25.01%	25.45%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.